What is the current market size?

The Intravenous Treatment market size was valued at USD 1.2 billion in 2023, driven by rising demand for rapid drug delivery and hospitalization rates.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, supported by advancements in personalized medicine and oncology therapies.

What are the key growth drivers?

Key drivers include the prevalence of chronic diseases, adoption of IV-based therapies for autoimmune disorders, and expanding geriatric populations.

What challenges does the market face?

High treatment costs, stringent regulatory approvals, and risks of complications like infections hinder market growth.

Which regions lead the market?

North America dominates the market, followed by Europe, due to advanced healthcare infrastructure and high R&D investments.

Who are the top competitors?

Leading companies include Baxter International, Fresenius Kabi, and B. Braun Melsungen AG, focusing on product innovation and strategic partnerships.

What opportunities exist for growth?

Emerging markets in Asia-Pacific offer untapped potential, along with growth in home healthcare and IV nutrition therapies.

How is technology impacting the market?

Smart infusion pumps and AI-driven monitoring systems are enhancing precision, safety, and patient outcomes in IV therapy delivery.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA enforce strict guidelines on IV product safety, sterility, and clinical trials to ensure quality standards.

Intravenous Treatment Market Intelligence Report 2026 — Updated June 2026

Intravenous Treatment by Application (Hospitals and Clinics, Outpatient clinic, Home Care), by Types (Peripheral Parenteral Nutrition, Total Parenteral Nutrition), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 8.3%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 8.3%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Intravenous Treatment Market Overview

The Intravenous Treatment market encompasses the delivery of therapeutic agents directly into the bloodstream, primarily for rapid efficacy in critical care, oncology, and chronic disease management. As healthcare systems prioritize precision and efficiency, the Intravenous Treatment market size is projected to reflect robust industry expansion, driven by technological innovation and rising demand for outpatient care. This report analyzes the growth outlook for the 2026–2033 forecast period, with a focus on regional dynamics, competitive strategies, and macroeconomic tailwinds.

Loading chart…

In 2025, the Intravenous Treatment market size reached $12.5 billion, with a forecasted CAGR of 6.8% through 2033. Key drivers include macro shifts such as the adoption of smart infusion pumps to reduce dosing errors, regulatory mandates for safer drug administration, and the transition to home-based IV therapies. North America remains the largest market due to advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by rising chronic disease prevalence and expanding hospital networks. Strategic partnerships among top IV therapy suppliers and innovation in biologics delivery are intensifying competitive pressures, particularly in oncology and rare disease therapies.

Report Overview

Report Attribute	Details
Market size value in 2025	12.50 billion
Revenue forecast in 2033	23.66 billion
Growth rate	CAGR of 8.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ICU Medical Inc.; B. Braun Melsungen AG; Fresenius Kabi AG; Baxter; Amanta Healthcare; Terumo Medical Corporation; Grifols S.A.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advancements in infusion technologies are propelling the Intravenous Treatment market size. Innovations such as smart IV pumps and disposable infusion systems enhance treatment accuracy and reduce hospital-acquired infections, aligning with rising patient safety standards.

Growing prevalence of chronic diseases is a key growth forecast catalyst. Conditions like diabetes, cancer, and autoimmune disorders require frequent IV therapies, driving demand for targeted drug delivery solutions.

Restraints2 items

High treatment costs compared to oral alternatives limit adoption in cost-sensitive markets. Insurance coverage gaps and out-of-pocket expenses hinder accessibility for patients in emerging economies.

Regulatory complexities in drug approvals and device certifications delay market entry. Stringent compliance requirements across regions like the EU and U.S. increase operational costs for manufacturers.

Opportunities2 items

Expansion into emerging markets offers untapped growth. Increasing healthcare infrastructure investments in India and Southeast Asia present opportunities for IV treatment adoption.

Home healthcare trends are driving demand for portable IV systems. Patient preference for at-home treatments and telehealth integration could reshape the Intravenous Treatment market landscape.

Challenges2 items

Supply chain disruptions threaten product availability. Raw material shortages and geopolitical tensions, particularly for critical components like syringes and vials, risk production delays.

Counterfeit drug proliferation poses safety and reputational risks. The Intravenous Treatment market must invest in anti-counterfeiting technologies to maintain trust in high-stakes therapeutic applications.

Market Segmentation

Loading chart…

Application segmentation in the Intravenous Treatment market reveals distinct demand drivers. The Hospital Settings segment dominates, accounting for 65% of the market, driven by acute care requirements, surgical procedures, and chronic disease management. Hospitals prioritize rapid, controlled drug delivery and fluid replacement, which aligns with IV therapy's efficiency. Conversely, the Home Healthcare segment constitutes 35%, fueled by post-discharge patient monitoring and self-administration devices. This growth reflects increasing patient preference for home-based care and advancements in portable IV systems. Together, these applications underscore the market's dual reliance on institutional and decentralized healthcare ecosystems.

Types segmentation highlights technological and functional differentiation. The Infusion Pumps category, including syringe, ambulatory, and volumetric pumps, accounts for 45% of the market. These devices offer precision dosing, critical for oncology and neonatal care, and are bolstered by smart pump integration. The IV Fluids segment, representing 55%, includes isotonic, hypertonic, and hypotonic solutions, serving as foundational components for drug administration and hydration. Fluids' higher market share is attributed to their universal applicability across therapies. Both categories collectively define the market taxonomy, with infusion pumps driving innovation while IV fluids ensure foundational market stability.

Intravenous Treatment Segmentation Breakdown7 items

Application

Hospitals and Clinics

Outpatient clinic

Home Care

Types

Peripheral Parenteral Nutrition

Total Parenteral Nutrition

Regional Insights

Loading chart…

North America dominates the Intravenous Treatment market with a 38% share, driven by advanced healthcare infrastructure, high adoption of innovative therapies, and robust R&D investments. The region benefits from mature ecosystems, supportive policies like the FDA’s accelerated approval pathways, and a large patient pool with chronic diseases.

Europe holds 28%, fueled by stringent regulatory frameworks ensuring treatment quality, an aging population driving demand, and cross-border collaborations among pharmaceutical and healthcare stakeholders. Germany and France lead in adoption, supported by universal healthcare access and public-private investments.

The Asia Pacific region is the fastest-growing market, projected to expand at a CAGR exceeding 12% through 2030. Key drivers include rising chronic disease prevalence, expanding healthcare access in India and China, and government initiatives like Japan’s digital health transformation. However, infrastructure gaps in rural areas limit growth potential.

Latin America accounts for 8%, with Brazil and Mexico emerging as hubs due to improving public healthcare funding and increased partnerships with global IV therapy providers. Regulatory harmonization under Mercosur and private-sector investments in hospital infrastructure are key enablers.

The Middle East & Africa region represents 4% of the market, constrained by fragmented healthcare systems but showing potential through UAE-led medical tourism initiatives and South Africa’s growing biopharma sector. Public-private partnerships and telehealth integration will be critical for regional forecast optimism.

Competitive Landscape

The Intravenous Treatment market is moderately consolidated, with a mix of global and regional players such as ICU Medical Inc., B. Braun Melsungen AG, and Fresenius Kabi AG dominating key geographies. The Intravenous Treatment key players leverage competitive advantages through pricing flexibility, regulatory approvals, and product innovation. Distribution networks and partnerships with healthcare providers remain critical differentiators, while technological advancements in infusion devices and smart delivery systems are reshaping market positioning. Market fragmentation persists in emerging economies, where local manufacturers target cost-sensitive segments through low-cost, standardized offerings.

Strategic priorities include R&D investment for next-generation IV solutions and geographic expansion into Asia-Pacific and Latin America. Companies differentiate through proprietary technologies, such as antimicrobial catheters or closed-system drug delivery platforms, or through cost leadership in generic IV solutions. A notable challenge is margin pressure from payers demanding lower pricing, compounded by rising compliance costs from evolving FDA and ISO standards. Supply chain disruptions further strain operations, particularly for firms reliant on single-source raw material suppliers.

ICU Medical Inc. focuses on regional expansion in North America through hospital partnerships

B. Braun Melsungen AG prioritizes product innovation in high-end IV infusion systems

Fresenius Kabi AG emphasizes vertical integration to optimize cost structures

Baxter strengthens its portfolio via OEM tie-ups for peripheral IV catheters

Amanta Healthcare targets emerging markets with localized manufacturing hubs

Terumo Medical Corporation invests in R&D for disposable IV components

Key Intravenous Treatment Companies7 items

ICU Medical Inc.

B. Braun Melsungen AG

Fresenius Kabi AG

Baxter

Amanta Healthcare

Terumo Medical Corporation

Grifols S.A.

Market Ecosystem

The Intravenous Treatment ecosystem spans upstream raw material suppliers, midstream manufacturers and technology integrators, and downstream healthcare delivery channels. Value is generated through the design, production, and distribution of IV therapy solutions, with critical dependencies on regulatory compliance, supply chain stability, and clinical adoption. The value chain analysis underscores interdependencies between component quality, device innovation, and patient access.

Raw material/component suppliers — provide sterile plastics, glass vials, and pharmaceutical compounds for IV formulation

Pharmaceutical manufacturers — produce IV drugs, nutritional solutions, and electrolyte mixtures

Medical device OEMs — design infusion pumps, IV bags, and administration sets

System integrators — configure IV therapy systems for hospital automation and monitoring

Distributors/wholesalers — manage logistics for hospitals, clinics, and home healthcare providers

Healthcare providers — administer IV treatments across acute care, ambulatory, and home settings

Regulatory bodies — enforce standards for product safety, sterility, and clinical efficacy

Control points reside with regulators governing approval pathways and quality benchmarks, while raw material availability affects production scalability. Healthcare providers exert influence through procurement decisions, though switching costs between suppliers remain low due to standardized interfaces. Partnerships between device manufacturers and pharmaceutical firms strengthen interoperability, while regional disparities in reimbursement policies create friction in market access.

Recent Industry Insights

The Intravenous Treatment industry trends have evolved rapidly over the past 18 months, driven by innovation and shifting healthcare priorities. Strategic partnerships have emerged, such as collaborations between IV therapy providers and home healthcare platforms to expand access to remote treatments. In mergers & acquisitions, major pharmaceutical firms have acquired niche infusion service companies to strengthen their market presence, while private equity groups have invested heavily in regional IV treatment centers. Product launches highlight advancements in smart IV delivery systems, with AI-enabled devices improving dosage accuracy and patient monitoring. Regulatory bodies, including the FDA, have updated sterility and labeling standards for IV solutions, prompting manufacturers to adopt stricter quality controls. A notable shift in consumer trends reflects growing demand for at-home IV therapies, fueled by post-pandemic preferences for decentralized care. Meanwhile, funding rounds have accelerated, with startups securing series B investments to scale telehealth-integrated IV services and portable infusion technologies. These developments underscore the sector’s move toward personalized, technology-driven care models.

Analyst Overview

The Intravenous Treatment market outlook remains robust, driven by rising demand for rapid drug delivery and expanding applications in chronic disease management. Market attractiveness is underscored by growth in hospitalization rates, aging populations, and advancements in home infusion therapies. Competitive intensity is moderate, with established players leveraging scale and innovation to maintain dominance, while niche players target specialized segments like oncology and nutrition therapies.

Long-term growth is poised to accelerate, supported by increasing healthcare digitization and adoption of smart IV infusion systems. The innovation landscape is dynamic, focusing on AI-integrated devices, reduced contamination risks, and sustainable packaging. Demand-supply balance is stable, though raw material shortages and regulatory delays pose intermittent challenges. Key risk factors include stringent compliance requirements, pricing pressures in emerging markets, and supply chain vulnerabilities from geopolitical tensions.

Critical Insights for Decision-Makers3 items

Prioritize R&D in AI-driven IV systems for competitive differentiation

Strengthen supply chain resilience to mitigate raw material risks

Monitor regulatory shifts impacting product approvals and market access

12 items

1. Executive Summary

2. Intravenous Treatment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Intravenous Treatment Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Intravenous Treatment Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Intravenous Treatment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Intravenous Treatment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Intravenous Treatment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Intravenous Treatment Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Intravenous Treatment Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Intravenous Treatment Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Intravenous Treatment Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Intravenous Treatment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Intravenous Treatment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Intravenous Treatment Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Intravenous Treatment Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Intravenous Treatment Market Competition by Key Manufacturers

9.1. Global Intravenous Treatment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Intravenous Treatment: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. ICU Medical Inc.

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. B. Braun Melsungen AG

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Fresenius Kabi AG

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Baxter

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Amanta Healthcare

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Terumo Medical Corporation

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Grifols S.A.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Intravenous Treatment Market

Figure 4: Global Intravenous Treatment Market: Drivers

Figure 5: Global Intravenous Treatment Market: Challenges

Figure 6: Global Intravenous Treatment Market: Trends

Figure 7: Global Intravenous Treatment Market: Opportunity

Figure 8: Global Intravenous Treatment Market: Restraint

Figure 9: Global Intravenous Treatment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Intravenous Treatment Market Value (USD Million) By Region

Figure 19: Global Intravenous Treatment Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Intravenous Treatment Market Value (USD Million) By Region

Figure 27: Global Intravenous Treatment Market Share (%) By: Regions (2032)

Figure 28: Global Intravenous Treatment Market Volume (K) By Region

Figure 29: Global Intravenous Treatment Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Intravenous Treatment Market Value (USD Million) By Region

Figure 37: Global Intravenous Treatment Market Share (%) By: Regions (2032)

Figure 38: Global Intravenous Treatment Market Volume (K) By Region

Figure 39: Global Intravenous Treatment Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Intravenous Treatment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Intravenous Treatment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Intravenous Treatment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Intravenous Treatment Market Value (USD Million) By Region

Table 14: Global Intravenous Treatment Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Intravenous Treatment Market Volume (K) By Region

Table 31: Global Intravenous Treatment Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Intravenous Treatment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Intravenous Treatment Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Intravenous Treatment Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: ICU Medical Inc. Basic Information And Sales Area

Table 52: ICU Medical Inc.. Products Portfolio

Table 53: B. Braun Melsungen AG Basic Information And Sales Area

Table 54: B. Braun Melsungen AG. Products Portfolio

Table 55: Fresenius Kabi AG Basic Information And Sales Area

Table 56: Fresenius Kabi AG. Products Portfolio

Table 57: Baxter Basic Information And Sales Area

Table 58: Baxter. Products Portfolio

Table 59: Amanta Healthcare Basic Information And Sales Area

Table 60: Amanta Healthcare. Products Portfolio

Table 61: Terumo Medical Corporation Basic Information And Sales Area

Table 62: Terumo Medical Corporation. Products Portfolio

Table 63: Grifols S.A. Basic Information And Sales Area

Table 64: Grifols S.A.. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Intravenous Treatment Market Value (USD Million) By Region

Table 74: Global Intravenous Treatment Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Intravenous Treatment Market Volume (K) By Region

Table 91: Global Intravenous Treatment Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Intravenous Treatment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.50 billion
Revenue forecast in 2033	23.66 billion
Growth rate	CAGR of 8.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ICU Medical Inc.; B. Braun Melsungen AG; Fresenius Kabi AG; Baxter; Amanta Healthcare; Terumo Medical Corporation; Grifols S.A.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Expansion into emerging markets offers untapped growth. Increasing healthcare infrastructure investments in India and Southeast Asia present opportunities for IV treatment adoption.

Home healthcare trends are driving demand for portable IV systems. Patient preference for at-home treatments and telehealth integration could reshape the Intravenous Treatment market landscape.

Challenges2 items

Supply chain disruptions threaten product availability. Raw material shortages and geopolitical tensions, particularly for critical components like syringes and vials, risk production delays.

Market Segmentation

Loading chart…

Intravenous Treatment Segmentation Breakdown7 items

Application

Hospitals and Clinics

Outpatient clinic

Home Care

Types

Peripheral Parenteral Nutrition

Total Parenteral Nutrition

Regional Insights

Loading chart…

Competitive Landscape

ICU Medical Inc. focuses on regional expansion in North America through hospital partnerships

B. Braun Melsungen AG prioritizes product innovation in high-end IV infusion systems

Fresenius Kabi AG emphasizes vertical integration to optimize cost structures

Baxter strengthens its portfolio via OEM tie-ups for peripheral IV catheters

Amanta Healthcare targets emerging markets with localized manufacturing hubs

Terumo Medical Corporation invests in R&D for disposable IV components

Key Intravenous Treatment Companies7 items

ICU Medical Inc.

B. Braun Melsungen AG

Fresenius Kabi AG

Baxter

Amanta Healthcare

Terumo Medical Corporation

Grifols S.A.

Market Ecosystem

Raw material/component suppliers — provide sterile plastics, glass vials, and pharmaceutical compounds for IV formulation

Pharmaceutical manufacturers — produce IV drugs, nutritional solutions, and electrolyte mixtures

Medical device OEMs — design infusion pumps, IV bags, and administration sets

System integrators — configure IV therapy systems for hospital automation and monitoring

Distributors/wholesalers — manage logistics for hospitals, clinics, and home healthcare providers

Healthcare providers — administer IV treatments across acute care, ambulatory, and home settings

Regulatory bodies — enforce standards for product safety, sterility, and clinical efficacy

Recent Industry Insights

Analyst Overview

Critical Insights for Decision-Makers3 items

Prioritize R&D in AI-driven IV systems for competitive differentiation

Strengthen supply chain resilience to mitigate raw material risks

Monitor regulatory shifts impacting product approvals and market access

Table of Contents